Diabetic Retinopathy Genomics Study (DRGen) - Genetic Biomarkers of Diabetic Retinopathy
Anthropometry (1)
- BMI - Body mass index (BMI) at enrollment (phv00508708.v1.p1)
Biomarkers (11)
- Blood_Creatinine - Blood creatinine level (mg/dL) (phv00528352.v1.p1)
- Blood_Urea - Blood urea level (mg/dL) (phv00528354.v1.p1)
- Diastolic_BP - Diastolic blood pressure at enrollment (mmHg) (phv00508710.v1.p1)
- GFR - Most recent glomerular filtration rate (ml/min) (phv00508715.v1.p1)
- HbA1C - Single time point for glycated hemoglobin within 3 months (percentage) (phv00508704.v1.p1)
- HDL - HDL cholesterol (mg/dL) at a single time point (phv00508713.v1.p1)
- LDL - LDL cholesterol (mg/dL) at a single time point (phv00508712.v1.p1)
- Systolic_BP - Systolic blood pressure at enrollment (mmHg) (phv00508709.v1.p1)
- Total_Cholesterol - Total cholesterol (mg/dL) at a single time point (phv00508711.v1.p1)
- Triglyceride_2Y_AVG - Two year average of triglyceride level (mg/dL) (phv00528341.v1.p1)
- Urine_Creatinine - Urine creatinine level (mg/dL) (phv00528353.v1.p1)
Demographics (3)
- Age - Subject age at enrollment in years (phv00508698.v1.p1)
- Sex - Biological sex (phv00508699.v1.p1)
- SEX - Biological sex (phv00508694.v1.p1)
Disease Events (9)
- Cancer_History - Whether or not the patient has been diagnosed with a cancer (phv00528347.v1.p1)
- CVD - Whether or not the patint has a cardiovascular disorder (phv00528351.v1.p1)
- Diabetes_Type - T1D or T2D (phv00508701.v1.p1)
- DM_Duration - Duration of diabetes in years (phv00508702.v1.p1)
- ESRD_Dialysis - Whether or not the patient undergoes dialysis or got diagnosed with end-stage renal disease (ESRD) (phv00528355.v1.p1)
- Family_History_Diabetes - Whether or not a family member has diabetes (phv00528344.v1.p1)
- Hypertension - Whether or not the patient has been diagnosed with hypertension (phv00528345.v1.p1)
- Nephropathy - Whether or not the patient has been diagnosed with nephropathy (phv00528349.v1.p1)
- Neuropathy - Whether or not the patient has been diagnosed with neuropathy (phv00528350.v1.p1)
General Health (7)
- Anti-VEGF_Drug - Whether the subject took Avastin or Eylea (phv00508719.v1.p1)
- CRT_Baseline - Baseline central retinal thickness (in micrometers) before the start of anti-VEGF therapy (phv00508716.v1.p1)
- CRT_Change - Percentage change in central retinal thickness (in micrometers) three months after anti-VEGF therapy (phv00508718.v1.p1)
- CRT_Final - Central retinal thickness (in micrometers) after three months of the start of anti-VEGF therapy (phv00508717.v1.p1)
- DR_Phenotype - Diabeteic retinopathy status (phv00528343.v1.p1)
- Ocular_Treatment - Whether or not the patient has been treated for an ocular condition (phv00528348.v1.p1)
- Response_to_VEGF_Treatment - Whether subject's response to anti-VEGF therapy was good or poor (phv00508720.v1.p1)
Medications (4)
- ACEinh - Whether or not the subject used an ACE Inhibitor (phv00508705.v1.p1)
- BetaBlock - Whether or not the subject used beta blockers (phv00508707.v1.p1)
- CalciumChan - Whether or not the subject used calcium channel blockers (phv00508706.v1.p1)
- Insulin - Whether or not the subject used exogenous insulin therapy (phv00508703.v1.p1)
Race and Ethnicity (1)
- Race/Ethnicity - Self-reported race (phv00508700.v1.p1)
Substance Use (1)
- Smoking_History - Smoker or non-smoker (phv00528346.v1.p1)
Other (13)
- Additional_Disorders - Presence of other disease (phv00528342.v1.p1)
- ANALYTE_TYPE - Analyte type (phv00508723.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00508722.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00508693.v1.p1)
- HDL_2Y_AVG - Two year average of HDL cholesterol (mg/dL) (phv00528340.v1.p1)
- IS_TUMOR - Tumor status (phv00508724.v1.p1)
- LDL_2Y_AVG - Two year average of LDL cholesterol (mg/dL) (phv00528339.v1.p1)
- SAMPLE_ID - Sample ID (phv00508721.v1.p1)
- SAMPLE_ID - Sample ID (phv00508696.v1.p1)
- SUBJECT_ID - Participant ID (phv00508697.v1.p1)
- SUBJECT_ID - Subject ID (phv00508692.v1.p1)
- SUBJECT_ID - Subject ID (phv00508695.v1.p1)
- Total_Cholesterol_2Y_AVG - Two year average of total cholesterol (mg/dL) (phv00528338.v1.p1)